study,trt,class,n,r
allen 2017,placebo,placebo,126,28
allen 2017,desvenlafaxine standard,snri,131,31
allen 2017,desvenlafaxine high,snri,131,29
allen 2017,desvenlafaxine high,snri,132,33
allen 2017,desvenlafaxine high,snri,139,25
arnold 2005,placebo,placebo,117,27
arnold 2005,duloxetine standard,snri,117,48
arnold 2005,duloxetine high,snri,115,47
arnold 2010: 1,placebo,placebo,133,11
arnold 2010: 1,esreboxetine unable to be categorised,snri,133,24
arnold 2010: 2,placebo,placebo,509,92
arnold 2010: 2,milnacipran standard,snri,516,143
arnold 2010: 3,placebo,placebo,248,41
arnold 2010: 3,duloxetine high,snri,249,62
arnold 2012: 1,placebo,placebo,153,55
arnold 2012: 1,duloxetine low,snri,153,56
arnold 2012: 2,placebo,placebo,275,33
arnold 2012: 2,esreboxetine standard,snri,274,49
arnold 2012: 2,esreboxetine standard,snri,279,56
arnold 2012: 2,esreboxetine high,snri,280,42
bateman 2011,milnacipran unable to be categorised,snri,79,20
bateman 2011,placebo,placebo,21,3
chappell 2008,placebo,placebo,167,30
chappell 2008,duloxetine high,snri,158,37
mease 2009,placebo,placebo,145,38
mease 2009,milnacipran standard,snri,128,44
mease 2009,milnacipran high,snri,239,88
miki 2016,placebo,placebo,211,33
miki 2016,mirtazapine standard,nassa,211,41
russell 2008,placebo,placebo,144,31
russell 2008,duloxetine standard,snri,79,29
russell 2008,duloxetine standard,snri,150,49
russell 2008,duloxetine high,snri,147,53
vitton 2004,placebo,placebo,28,6
vitton 2004,milnacipran unable to be categorised,snri,46,12
vitton 2004,milnacipran unable to be categorised,snri,51,15
chappell 2009: 2,placebo,placebo,120,35
chappell 2009: 2,duloxetine high,snri,111,52
chappell 2011,placebo,placebo,128,28
chappell 2011,duloxetine high,snri,128,49
frakes 2011,placebo,placebo,260,35
frakes 2011,duloxetine high,snri,264,73
schukro 2016,placebo,placebo,25,2
schukro 2016,duloxetine high,snri,25,10
shinichi 2016,placebo,placebo,226,89
shinichi 2016,duloxetine standard,snri,232,131
skljarevski 2009,placebo,placebo,113,33
skljarevski 2009,duloxetine low,snri,56,12
skljarevski 2009,duloxetine standard,snri,110,38
skljarevski 2009,duloxetine high,snri,109,40
skljarevski 2010: 1,placebo,placebo,115,22
skljarevski 2010: 1,duloxetine high,snri,109,34
skljarevski 2010: 2,placebo,placebo,199,69
skljarevski 2010: 2,duloxetine standard,snri,195,95
uchio 2018,placebo,placebo,176,69
uchio 2018,duloxetine standard,snri,177,114
wang 2017,placebo,placebo,197,68
wang 2017,duloxetine standard,snri,194,83
allen 2014,placebo,placebo,89,23
allen 2014,desvenlafaxine standard,snri,63,22
allen 2014,desvenlafaxine high,snri,86,32
allen 2014,desvenlafaxine high,snri,99,36
allen 2014,desvenlafaxine high,snri,68,22
enomoto 2018,pregabalin ,nonad,149,62
enomoto 2018,duloxetine low,snri,152,62
gao 2010,placebo,placebo,109,55
gao 2010,duloxetine high,snri,106,57
gao 2015,placebo,placebo,198,57
gao 2015,duloxetine standard,snri,200,84
gillving 2021,terbutaline ,nonad,39,2
gillving 2021,imipramine standard,tca,44,12
gillving 2021,placebo,placebo,38,3
goldstein 2005,placebo,placebo,90,29
goldstein 2005,duloxetine low,snri,89,46
goldstein 2005,duloxetine standard,snri,89,55
goldstein 2005,duloxetine high,snri,91,57
holbech 2015,placebo,placebo,69,4
holbech 2015,pregabalin ,nonad,69,8
holbech 2015,imipramine standard,tca,69,14
holbech 2015,pregabalin + imipramine standard,tca,69,19
kaur 2011,amitriptyline unable to be categorised,tca,58,32
kaur 2011,duloxetine low,snri,58,34
raskin 2005,placebo,placebo,113,34
raskin 2005,duloxetine standard,snri,113,57
raskin 2005,duloxetine high,snri,114,44
razazian 2014,carbamazepine ,nonad,85,35
razazian 2014,pregabalin ,nonad,86,66
razazian 2014,venlafaxine standard,snri,86,36
richards 2015,placebo,placebo,59,14
richards 2015,venlafaxine unable to be categorised,snri,64,32
rowbotham 2004,placebo,placebo,80,27
rowbotham 2004,venlafaxine high,snri,82,46
smith 2013,placebo,placebo,94,8
smith 2013,duloxetine standard,snri,87,18
tesfaye 2013,pregabalin ,nonad,374,104
tesfaye 2013,duloxetine standard,snri,375,151
vollmer 2014,placebo,placebo,121,16
vollmer 2014,duloxetine standard,snri,115,24
wernicke 2006,placebo,placebo,106,29
wernicke 2006,duloxetine standard,snri,110,47
wernicke 2006,duloxetine high,snri,111,59
yasuda 2011,placebo,placebo,167,33
yasuda 2011,duloxetine low,snri,85,32
yasuda 2011,duloxetine standard,snri,86,35
loldrup 1989,placebo,placebo,66,25
loldrup 1989,clomipramine standard,tca,62,30
loldrup 1989,mianserin high,teca,64,29